These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22189027)

  • 1. Tumor histology and location predict deep nuclei toxicity: Implications for late effects from focal brain irradiation.
    Plaga A; Shields LB; Sun DA; Vitaz TW; Spalding AC
    Med Dosim; 2012; 37(3):276-9. PubMed ID: 22189027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity.
    Kortmann RD; Timmermann B; Taylor RE; Scarzello G; Plasswilm L; Paulsen F; Jeremic B; Gnekow AK; Dieckmann K; Kay S; Bamberg M
    Strahlenther Onkol; 2003 Sep; 179(9):585-97. PubMed ID: 14628124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors.
    Pehlivan B; Ares C; Lomax AJ; Stadelmann O; Goitein G; Timmermann B; Schneider RA; Hug EB
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1432-40. PubMed ID: 22349042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
    Hein PA; Gladstone DJ; Bellerive MR; Hug EB
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.
    Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
    Eur Urol; 2011 Dec; 60(6):1142-8. PubMed ID: 21855208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity modulated radiation therapy versus three dimensional conformal radiation therapy for treatment of high grade glioma: a radiobiological modeling study.
    De La Fuente Herman T; Ahmad And S; Vlachaki MT
    J Xray Sci Technol; 2010; 18(4):393-402. PubMed ID: 21045276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas.
    Shaffer R; Nichol AM; Vollans E; Fong M; Nakano S; Moiseenko V; Schmuland M; Ma R; McKenzie M; Otto K
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1177-84. PubMed ID: 19560880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation.
    Hepel JT; Tokita M; MacAusland SG; Evans SB; Hiatt JR; Price LL; DiPetrillo T; Wazer DE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1290-6. PubMed ID: 19395195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of conventional radiotherapy and intensity-modulated radiotherapy for post-operative radiotherapy for primary extremity soft tissue sarcoma.
    Stewart AJ; Lee YK; Saran FH
    Radiother Oncol; 2009 Oct; 93(1):125-30. PubMed ID: 19604591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence.
    Shah R; Vattoth S; Jacob R; Manzil FF; O'Malley JP; Borghei P; Patel BN; Curé JK
    Radiographics; 2012; 32(5):1343-59. PubMed ID: 22977022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy.
    Jalali R; Mallick I; Dutta D; Goswami S; Gupta T; Munshi A; Deshpande D; Sarin R
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):974-9. PubMed ID: 19864079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain?
    Hermanto U; Frija EK; Lii MJ; Chang EL; Mahajan A; Woo SY
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1135-44. PubMed ID: 17208388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Volumetric changes following 125I interstitial brachytherapy of gliomas].
    Julow J; Viola A; Major T; Mangel L; Bajzik G; Repa I; Sági S; Valálik I; Emri M; Trón L; Németh G
    Ideggyogy Sz; 2005 Mar; 58(3-4):120-32. PubMed ID: 15887415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
    Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing temporal lobe dose with five-field intensity-modulated radiotherapy for treatment of pituitary macroadenomas.
    Parhar PK; Duckworth T; Shah P; DeWyngaert JK; Narayana A; Formenti SC; Shah JN
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):379-84. PubMed ID: 20015598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas.
    Greenberger BA; Pulsifer MB; Ebb DH; MacDonald SM; Jones RM; Butler WE; Huang MS; Marcus KJ; Oberg JA; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1060-1068. PubMed ID: 25035209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
    Michalski JM; Winter K; Purdy JA; Perez CA; Ryu JK; Parliament MB; Valicenti RK; Roach M; Sandler HM; Markoe AM; Cox JD
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):735-42. PubMed ID: 14967428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.